S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

OptimizeRx (OPRX) News Today

$9.32
-0.03 (-0.32%)
(As of 04/19/2024 08:51 PM ET)
SourceHeadline
MarketBeat logoFinancial Comparison: OptimizeRx (NASDAQ:OPRX) & ICTS International (OTCMKTS:ICTSF)
americanbankingnews.com - April 22 at 1:12 AM
globenewswire.com logoOptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
globenewswire.com - April 18 at 7:30 AM
MarketBeat logoQ1 2024 EPS Estimates for OptimizeRx Co. Decreased by William Blair (NASDAQ:OPRX)
americanbankingnews.com - April 18 at 5:46 AM
MarketBeat logoOptimizeRx (NASDAQ:OPRX) Receives "Market Outperform" Rating from JMP Securities
americanbankingnews.com - April 17 at 4:44 AM
marketbeat.com logoOptimizeRx (NASDAQ:OPRX) Earns "Market Outperform" Rating from JMP Securities
marketbeat.com - April 16 at 12:04 PM
globenewswire.com logoOptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
globenewswire.com - April 16 at 7:00 AM
stockhouse.com logoOptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row
stockhouse.com - April 13 at 12:40 AM
MarketBeat logoOptimizeRx Co. (NASDAQ:OPRX) Given Average Recommendation of "Moderate Buy" by Analysts
americanbankingnews.com - April 12 at 4:28 AM
finance.yahoo.com logoOptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
finance.yahoo.com - April 11 at 9:21 AM
finance.yahoo.com logoOptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
finance.yahoo.com - April 11 at 9:21 AM
globenewswire.com logoOptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row
globenewswire.com - April 11 at 7:30 AM
investorplace.com logo7 Top Undervalued Stocks Primed for a Multibagger Recovery
investorplace.com - April 6 at 6:00 AM
markets.businessinsider.com logoOptimizeRx: A Strong Buy on Strategic Acquisitions and Innovative Platform Expansion
markets.businessinsider.com - April 4 at 8:50 AM
marketbeat.com logoJMP Securities Begins Coverage on OptimizeRx (NASDAQ:OPRX)
marketbeat.com - April 4 at 8:31 AM
au.lifestyle.yahoo.com logoTesla blames sales drop on Houthi attacks and arson in Germany
au.lifestyle.yahoo.com - April 2 at 5:24 PM
msn.com logoAriana Madix To Host ‘Love Island USA’ as Sarah Hyland Departs Franchise
msn.com - April 1 at 8:53 PM
au.news.yahoo.com logoCanoo spent double its annual revenue on the CEO’s private jet in 2023
au.news.yahoo.com - April 1 at 8:53 PM
finance.yahoo.com logoOptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call Transcript
finance.yahoo.com - April 1 at 3:52 PM
marketbeat.com logoOptimizeRx (NASDAQ:OPRX) Stock Rating Reaffirmed by Stifel Nicolaus
marketbeat.com - April 1 at 12:23 PM
finance.yahoo.com logoQ4 2023 OPTIMIZERx Corp Earnings Call
finance.yahoo.com - March 29 at 7:57 AM
investorplace.com logoOPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023
investorplace.com - March 28 at 11:31 PM
msn.com logoOptimizeRx Q4 revenue $28.4M
msn.com - March 28 at 3:24 PM
msn.com logoOptimizeRx Q4 2023 Earnings Preview
msn.com - March 27 at 2:32 PM
benzinga.com logo7OPRX : OptimizeRx Earnings Preview
benzinga.com - March 27 at 2:32 PM
globenewswire.com logoOptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
globenewswire.com - March 25 at 7:30 AM
seekingalpha.com logoOptimizeRx: Exponential Growth Drives The Valuation Cheaper
seekingalpha.com - March 23 at 7:19 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), AnaptysBio (ANAB) and REPRO-MED Systems (KRMD)
markets.businessinsider.com - March 13 at 2:21 PM
markets.businessinsider.com logoOptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
markets.businessinsider.com - March 11 at 7:50 PM
globenewswire.com logoOptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
globenewswire.com - March 11 at 4:30 PM
marketbeat.com logoKennedy Capital Management LLC Buys Shares of 555,675 OptimizeRx Co. (NASDAQ:OPRX)
marketbeat.com - March 8 at 7:45 AM
stockhouse.com logoOptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach Effort
stockhouse.com - March 6 at 4:11 PM
globenewswire.com logoOptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach Effort
globenewswire.com - March 4 at 3:51 PM
marketbeat.com logoOptimizeRx Co. (NASDAQ:OPRX) Stock Holdings Lowered by Avenir Corp
marketbeat.com - March 2 at 12:17 PM
benzinga.com logoOptimizeRx Stock (NASDAQ:OPRX), Short Interest Report
benzinga.com - February 23 at 1:58 PM
globenewswire.com logoOptimizeRx to Participate in Upcoming Investor Conferences
globenewswire.com - February 21 at 7:30 AM
marketbeat.com logoOptimizeRx Co. (NASDAQ:OPRX) Short Interest Down 19.6% in January
marketbeat.com - February 13 at 11:28 AM
marketbeat.com logoOptimizeRx Co. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by Brokerages
marketbeat.com - January 28 at 4:32 AM
marketbeat.com logoJacob Asset Management of New York LLC Buys 85,720 Shares of OptimizeRx Co. (NASDAQ:OPRX)
marketbeat.com - January 17 at 9:02 AM
marketbeat.com logoBrokers Issue Forecasts for OptimizeRx Co.'s FY2023 Earnings (NASDAQ:OPRX)
marketbeat.com - January 12 at 6:36 AM
marketbeat.com logoOptimizeRx Co. (NASDAQ:OPRX) General Counsel Marion Odence-Ford Sells 4,000 Shares
marketbeat.com - January 11 at 6:49 PM
marketbeat.com logoQ4 2024 Earnings Forecast for OptimizeRx Co. Issued By William Blair (NASDAQ:OPRX)
marketbeat.com - January 11 at 8:26 AM
marketbeat.com logoRoyal Bank of Canada Raises OptimizeRx (NASDAQ:OPRX) Price Target to $17.00
marketbeat.com - January 10 at 10:20 AM
finanznachrichten.de logoOptimizeRx Corporation: OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
finanznachrichten.de - January 9 at 10:32 AM
finance.yahoo.com logoOptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
finance.yahoo.com - January 9 at 10:32 AM
msn.com logoBarclays Initiates Coverage of OptimizeRx (OPRX) with Equal-Weight Recommendation
msn.com - January 4 at 1:43 AM
marketbeat.com logoBarclays Initiates Coverage on OptimizeRx (NASDAQ:OPRX)
marketbeat.com - January 3 at 8:30 AM
marketbeat.com logoOptimizeRx Co. (NASDAQ:OPRX) Given Consensus Recommendation of "Buy" by Analysts
marketbeat.com - January 3 at 8:25 AM
realmoney.thestreet.com logoOptimizeRx initiated with neutral view at Barclays
realmoney.thestreet.com - January 3 at 5:43 AM
finance.yahoo.com logoShould You Exit OptimizeRx Corp. (OPRX)?
finance.yahoo.com - December 26 at 7:35 AM
benzinga.com logoOptimizeRx Stock (NASDAQ:OPRX) Dividends: History, Yield and Dates
benzinga.com - December 23 at 9:00 AM
Get OptimizeRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

OPRX Media Mentions By Week

OPRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OPRX
News Sentiment

-0.09

0.47

Average
Computer and Technology
News Sentiment

OPRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OPRX Articles
This Week

10

2

OPRX Articles
Average Week

Get OptimizeRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:OPRX) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners